276
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Choroidal Variations in Diabetic Macular Edema: Fluorescein Angiography and Optical Coherence Tomography

, , , &

References

  • Romero-Aroca P. Managing diabetic macular edema: The leading cause of diabetes blindness. World J Diabetes. 2011;2(6):98–104. doi:10.4239/wjd.v2.i6.98.
  • Rayess N, Rahimy E, Ying GS, Bagheri N, Ho AC, Regillo CD, Vander JF, Hsu J. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol. 2015;159(1):85–91. doi:10.1016/j.ajo.2014.09.033.
  • Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2013;54(5):3378–84. doi:10.1167/iovs.12-11503.
  • Esmaeelpour M, Brunner S, Ansari-Shahrezaei S, Nemetz S, Považay B, Kajic V, Drexler W, Binder S. Choroidal thinning in diabetes type 1 detected by 3-dimensional 1060 nm optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(11):6803–09. doi:10.1167/iovs.12-10314.
  • Esmaeelpour M, Považay B, Hermann B, Hofer B, Kajic V, Hale SL, North RV, Drexler W, Sheen NJL. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52(8):5311–16. doi:10.1167/iovs.10-6875.
  • Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina. 2012;32(3):563–68. doi:10.1097/IAE.0B013E31822F5678.
  • Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5):807–22.
  • Antcliff RJ, Stanford MR, Chauhan DS, Graham EM, Spalton DJ, Shilling JS, Ffytche TJ, Marshall J. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology. 2000;107(3):593–99. doi:10.1016/S0161-6420(99)00087-1.
  • Byeon SH, Chu YK, Lee H, Lee SY, Kwon OW. Foveal ganglion cell layer damage in ischemic diabetic maculopathycorrelation of optical coherence tomographic and anatomic changes. Ophthalmology. 2009;116(10):1949–59. doi:10.1016/j.ophtha.2009.06.066.
  • Browning DJ. Potential pitfalls from variable optical coherence tomograph displays in managing diabetic macular edema. Am J Ophthalmol. 2003;136(3):555–57. doi:10.1016/S0002-9394(03)00387-8.
  • Browning DJ, McOwen MD, Bowen RJ, O’Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology. 2004;111(4):712–15. doi:10.1016/j.ophtha.2003.06.028.
  • Moreira RO, Trujillo FR, Meirelles RM, Ellinger VC, Zagury L. Use of optical coherence tomography (OCT) and indirect ophthalmoscopy in the diagnosis of macular edema in diabetic patients. Int Ophthalmol. 2001;24(6):331–36. doi:10.1023/B:INTE.0000006784.52885.e9.
  • Sander B, Best J, Johansen S, Kessel L, Moldow B. Fluorescein transport through the blood-aqueous and blood-retinal barriers in diabetic macular edema. Curr Eye Res. 2003;27(4):247–52. doi:10.1076/ceyr.27.4.247.16596.
  • Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol. 2006;142(3):405–12. doi:10.1016/j.ajo.2006.04.023.
  • Silpa-Archa S, Maleki A, Roohipoor R, Preble JM, Foster CS. Analysis of three-dimensional choroidal volume with enhanced depth imaging findings in patients with birdshot retinochoroidopathy. Retina. 2016;36(9):1758–66. doi:10.1097/IAE.0000000000000969.
  • Barteselli G, Chhablani J, El-Emam S, Wang H, Chuang J, Kozak I, Cheng L, Bartsch D-U, Freeman WR. Choroidal volume variations with age, axial length, and sex in healthy subjects: A three-dimensional analysis. Ophthalmology. 2012;119(12):2572–78. doi:10.1016/j.ophtha.2012.06.065.
  • Chhablani J, Barteselli G, Wang H, El-Emam S, Kozak I, Doede AL, Bartsch D-U, Cheng L, Freeman WR. Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(4):2274–80. doi:10.1167/iovs.12-9435.
  • Gupta P, Jing T, Marziliano P, Cheung CY, Baskaran M, Lamoureux EL, Wong TY, Cheung CMG, Cheng C-Y. Distribution and determinants of choroidal thickness and volume using automated segmentation software in a population-based study. Am J Ophthalmol. 2015;159(2):293–301. doi:10.1016/j.ajo.2014.10.034.
  • Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1985;103(12):1796–806. doi:10.1001/archopht.1985.01050120030015.
  • Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82. doi:10.1016/S0161-6420(03)00475-5.
  • Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127(6):688–93. doi:10.1016/S0002-9394(99)00033-1.
  • Trichonas G, Kaiser PK. Optical coherence tomography imaging of macular oedema. Br J Ophthalmol. 2014;98(Suppl 2):i24–i29. doi:10.1136/bjophthalmol-2014-305305.
  • Cao J, McLeod S, Merges CA, Lutty GA. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol. 1998;116(5):589–97. doi:10.1001/archopht.116.5.589.
  • Fryczkowski AW, Sato SE, Hodes BL. Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol. 1988;20(8):299–305.
  • Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology. 1985;92(4):512–22. doi:10.1016/S0161-6420(85)34013-7.
  • Unsal E, Eltutar K, Zirtiloglu S, Dincer N, Ozdogan ES, Gungel H. Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol. 2014;8:637–42. doi:10.2147/OPTH.S59395.
  • Lee HK, Lim JW, Shin MC. Comparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography. Korean J Ophthalmol. 2013;27(6):433–39. doi:10.3341/kjo.2013.27.6.433.
  • Linsenmeier RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Invest Ophthalmol Vis Sci. 2000;41(10):3117–23.
  • De Freytas A, Gallego PR, Cisneros LA. Subfoveal choroidal thickness in eyes with diabetic macular oedema using swept source optical coherence tomography. Arch Soc Esp Oftalmol. 2016;91(5):228–31. doi:10.1016/j.oftal.2015.12.015.
  • Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol. 2004;137(2):313–22. doi:10.1016/j.ajo.2003.09.016.
  • Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res. 2004;36(5):241–49. doi:10.1159/000081203.
  • Scholl S, Augustin A, Loewenstein A, Rizzo S, Kupperman B. General pathophysiology of macular edema. Eur J Ophthalmol. 2011;21(Suppl 6):S10–S19. doi:10.5301/EJO.2010.6050.
  • Yanoff M, Fine BS, Brucker AJ, Eagle RJ. Pathology of human cystoid macular edema. Surv Ophthalmol. 1984;28(Suppl):505–11. doi:10.1016/0039-6257(84)90233-9.
  • Usui S, Ikuno Y, Akiba M, Maruko I, Sekiryu T, Nishida K, Iida T. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci. 2012;53(4):2300–07. doi:10.1167/iovs.11-8383.
  • Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(1):261–66. doi:10.1167/iovs.11-8782.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.